Department of Health and Social Care
We support ministers in leading the nation’s health and social care to help people live more independent, healthier lives for longer.
Shadow Ministers / Spokeperson
Liberal Democrat
Helen Morgan (LD - North Shropshire)Liberal Democrat Spokesperson (Health and Social Care)
Danny Chambers (LD - Winchester)
Liberal Democrat Spokesperson (Mental Health)
Scottish National Party
Seamus Logan (SNP - Aberdeenshire North and Moray East)Shadow SNP Spokesperson (Health and Social Care)
Green Party
Adrian Ramsay (Green - Waveney Valley)Green Spokesperson (Health)
Liberal Democrat
Baroness Pidgeon (LD - Life peer)Liberal Democrat Lords Spokesperson (Health)
Conservative
Damian Hinds (Con - East Hampshire)Shadow Secretary of State for Health and Social Care
Junior Shadow Ministers / Deputy Spokesperson
Conservative
Lord Kamall (Con - Life peer)Shadow Minister (Health and Social Care)
Caroline Johnson (Con - Sleaford and North Hykeham)
Shadow Minister (Health and Social Care)
Junior Shadow Ministers / Deputy Spokesperson
Conservative
Neil Shastri-Hurst (Con - Solihull West and Shirley)Shadow Parliamentary Under Secretary (Health and Social Care)
Gregory Stafford (Con - Farnham and Bordon)
Shadow Parliamentary Under Secretary (Health and Social Care)
Ministers of State
Karin Smyth (Lab - Bristol South)Minister of State (Department of Health and Social Care)
Diana Johnson (Lab - Kingston upon Hull North and Cottingham)
Minister of State (Department of Health and Social Care)
Alison McGovern (Lab - Birkenhead)
Minister of State (Department of Health and Social Care)
Chris McDonald (Lab - Stockton North)
Minister of State (Department of Health and Social Care)
Parliamentary Under-Secretaries of State
Baroness Merron (Lab - Life peer)Parliamentary Under-Secretary (Department of Health and Social Care)
James Frith (Lab - Bury North)
Parliamentary Under-Secretary (Department of Health and Social Care)
15:15
Correspondence
To ask His Majesty's Government what headcount they expect integrated care boards to have in March 2028 as part of …
These Regulations amend the Care and Support (Charging and Assessment of Resources) Regulations 2014 (“the 2014 Regulations”).
A Bill to make provision about health and social care.
15:01
News and Communications
Department of Health and Social Care Commons Appearances
Oral Answers to Questions is a regularly scheduled appearance where the Secretary of State and junior minister will answer at the Dispatch Box questions from backbench MPs
Other Commons Chamber appearances can be:- Urgent Questions where the Speaker has selected a question to which a Minister must reply that day
- Adjornment Debates a 30 minute debate attended by a Minister that concludes the day in Parliament.
- Oral Statements informing the Commons of a significant development, where backbench MP's can then question the Minister making the statement.
Westminster Hall debates are performed in response to backbench MPs or e-petitions asking for a Minister to address a detailed issue
Written Statements are made when a current event is not sufficiently significant to require an Oral Statement, but the House is required to be informed.
Most Recent Commons Appearances by Category
Bills currently before Parliament
Department of Health and Social Care does not have Bills currently before Parliament
Acts of Parliament created in the 2024 Parliament
A Bill to make provision about the supply of tobacco, vapes and other products, including provision prohibiting the sale of tobacco to people born on or after 1 January 2009 and provision about the licensing of retail sales and the registration of retailers; to enable product and information requirements to be imposed in connection with tobacco, vapes and other products; to control the advertising and promotion of tobacco, vapes and other products; and to make provision about smoke-free places, vape-free places and heated tobacco-free places.
This Bill received Royal Assent on 29th April 2026 and was enacted into law.
A Bill to Make provision about the prioritisation of graduates from medical schools in the United Kingdom and certain other persons for places on medical training programmes.
This Bill received Royal Assent on 5th March 2026 and was enacted into law.
A Bill to make provision to amend the Mental Health Act 1983 in relation to mentally disordered persons; and for connected purposes.
This Bill received Royal Assent on 18th December 2025 and was enacted into law.
Department of Health and Social Care - Secondary Legislation
Petitions
e-Petitions are administered by Parliament and allow members of the public to express support for a particular issue.
If an e-petition reaches 10,000 signatures the Government will issue a written response.
If an e-petition reaches 100,000 signatures the petition becomes eligible for a Parliamentary debate (usually Monday 4.30pm in Westminster Hall).
(19,962 in the last 7 days)
(10,620 in the last 7 days)
(4,534 in the last 7 days)
(3,611 in the last 7 days)
(2,326 in the last 7 days)
(63 in the last 7 days)
(19,962 in the last 7 days)
(3,611 in the last 7 days)
(4,534 in the last 7 days)
(125 in the last 7 days)
Petition Closed
Appoint a Maternity Commissioner to improve maternity care for mums and babies
Gov Responded - 28 Jan 2026 Debated on - 20 Apr 2026closed 2 months, 1 week ago
A 2024 parliamentary birth trauma inquiry recommended a Maternity Commissioner be appointed alongside a National Maternity Strategy to ensure mums and their babies were safe and looked after with professionalism and compassion.
Petition Closed
Remove power to cancel local government elections
closed 3 months, 3 weeks ago
Change the law to remove the power of the Secretary of State to cancel any further forthcoming local government, metropolitan borough, London borough or any other elections, for example, but not limited to, those due in May 2026.
Petition Closed
Review the evidence and fund the addition of SMA to the Newborn Screening Test
Gov Responded - 14 Jul 2026closed 1 month, 1 week ago
We urge the UK Government to fund and help fast-track the process to add SMA to the NHS newborn heel-prick test. SMA is a rare genetic condition with devastating consequences if not treated early. Every baby should be screened at birth to allow early diagnosis and access to life-changing treatment.
Departmental Select Committee
Health and Social Care Committee
Commons Select Committees are a formally established cross-party group of backbench MPs tasked with holding a Government department to account.
At any time there will be number of ongoing investigations into the work of the Department, or issues which fall within the oversight of the Department. Witnesses can be summoned from within the Government and outside to assist in these inquiries.
Select Committee findings are reported to the Commons, printed, and published on the Parliament website. The government then usually has 60 days to reply to the committee's recommendations.
11 Members of the Health and Social Care Committee
Health and Social Care Committee Member since 9th September 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 21st October 2024
Health and Social Care Committee Member since 28th October 2024
Health and Social Care Committee Member since 17th March 2025
Health and Social Care Committee: 9 Current Inquiries
Health and Social Care Committee: Previous Inquiries
50 most recent Written Questions
(View all written questions)Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
I refer the Hon Member to the answer provided on 22 April in response to Question 127201.
Parliamentary Under-Secretary (Department of Health and Social Care)
Estates Safety Fund schemes were selected by the National Health Service working with trusts and integrated care boards to prioritise the most urgent operational and safety risks, including ventilation requirements, and the schemes that will make the greatest difference to patients and staff.
No data is held on the proportion of the funding that will be directed towards the use of high-efficiency particulate air filters.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information is not held in the format requested.
Parliamentary Under-Secretary (Department of Health and Social Care)
The independent review into prevalence and support for mental health conditions, attention deficit hyperactivity disorder, and autism is examining changes in prevalence, need, and demand. Its interim report found that there is no single, simple explanation for rising levels of psychological distress and demand, and identified areas where the evidence remains uncertain.
The review is considering a range of factors that may be contributing to rising prevalence and demand for support. The final report, which will be published shortly, will bring together the full body of evidence and make recommendations on how the health system and wider public services can respond more effectively.
Parliamentary Under-Secretary (Department of Health and Social Care)
The requested information is not centrally held by the Department and could only be obtained for the purposes of answering this question at disproportionate cost.
Parliamentary Under-Secretary (Department of Health and Social Care)
On 29 July, the Prime Minister set out his objectives to reform the social care system and brought forward the timetable for Baroness Casey’s commission to inform that reform programme.
A range of research, evidence and policy proposals will be reviewed as part of that process, and we will continue to update Parliament on a regular basis.
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Noble Baroness to the detailed plans set out in my Written Statement HLWS1049 made on 12 November 2025, and to the impact assessment that has been laid before the House, a copy of which is attached. We will provide further updates on staffing matters on an ongoing basis as the plans we have set out are delivered.
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Noble Baroness to the detailed plans set out in my Written Statement HLWS1049 made on 12 November 2025, and to the impact assessment that has been laid before the House, a copy of which is attached. We will provide further updates on staffing matters on an ongoing basis as the plans we have set out are delivered.
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Noble Baroness to the detailed plans set out in my Written Statement HLWS1049 made on 12 November 2025, and to the impact assessment that has been laid before the House, a copy of which is attached. We will provide further updates on staffing matters on an ongoing basis as the plans we have set out are delivered.
Parliamentary Under-Secretary (Department of Health and Social Care)
The evidence review is expected to be completed during the second half of 2027, and the findings will be published shortly thereafter. We will consider the evidence as appropriate to inform future policy development.
Parliamentary Under-Secretary (Department of Health and Social Care)
No formal assessment has been made. The next consultation on NHS England’s Commercial Framework, currently planned for 2026/27, will seek views on commercial options including indication-specific pricing.
Parliamentary Under-Secretary (Department of Health and Social Care)
No formal assessment has been made. The next consultation on NHS England’s Commercial Framework, currently planned for 2026/27, will seek views on commercial options including indication-specific pricing.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information requested in HL3448, HL3450, and HL3451 is not centrally held by the Department.
With regard to HL3449, patients can complain directly to the provider that treated them or to NHS England, as the commissioner of adult gender services. They can also raise concerns with the Care Quality Commission or Healthwatch. If they remain unhappy after completing the National Health Service complaints process, they can ask the Parliamentary and Health Service Ombudsman to investigate. Information regarding the number of complaints received is not held centrally.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information requested in HL3448, HL3450, and HL3451 is not centrally held by the Department.
With regard to HL3449, patients can complain directly to the provider that treated them or to NHS England, as the commissioner of adult gender services. They can also raise concerns with the Care Quality Commission or Healthwatch. If they remain unhappy after completing the National Health Service complaints process, they can ask the Parliamentary and Health Service Ombudsman to investigate. Information regarding the number of complaints received is not held centrally.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information requested in HL3448, HL3450, and HL3451 is not centrally held by the Department.
With regard to HL3449, patients can complain directly to the provider that treated them or to NHS England, as the commissioner of adult gender services. They can also raise concerns with the Care Quality Commission or Healthwatch. If they remain unhappy after completing the National Health Service complaints process, they can ask the Parliamentary and Health Service Ombudsman to investigate. Information regarding the number of complaints received is not held centrally.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information requested in HL3448, HL3450, and HL3451 is not centrally held by the Department.
With regard to HL3449, patients can complain directly to the provider that treated them or to NHS England, as the commissioner of adult gender services. They can also raise concerns with the Care Quality Commission or Healthwatch. If they remain unhappy after completing the National Health Service complaints process, they can ask the Parliamentary and Health Service Ombudsman to investigate. Information regarding the number of complaints received is not held centrally.
Parliamentary Under-Secretary (Department of Health and Social Care)
Neil O'Brien
(Conservative - Harborough, Oadby and Wigston)
NHS England publishes annual Mental Health Act Statistics, including the total number of people detained under the Mental Health Act on 31 March each year. The latest data is available at the link below, and new data for the year ending 31 March 2026 will be published on 15 October:
Table 8a in the Mental Health Act Statistics, Annual Figures, 2024-25, available at the following link, provides information on discharges from hospital under court and prison disposal provisions, excluding Community Treatment Orders, broken down by section:
Figures are provided for both the number of discharges, and the length of detention. Data on patients detained under Part III of the Mental Health Act 1983 is not broken down by hospital security level.
Minister of State (Department of Health and Social Care)
Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
Shockat Adam
(Independent - Leicester South)
Further to the answer provided on 20 July in response to Question 18432, the clinical guideline remains in development through the PANS PANDAS Steering Group, under the leadership of the Royal College of Paediatrics and Child Health. The Steering Group brings together clinicians, professional organisations, families, and patient representatives, and as well as developing the clinical guideline, its work includes supporting education, research, and improved awareness of these conditions.
Once finalised, the National Institute for Health and Care Excellence anticipates reviewing the guideline and, if it considers it to be of sufficient quality, will signpost to it on its website with commentary on its strengths and limitations. The guideline will also help inform any future awareness and education activity, including the training curricula produced jointly by regulators, royal colleges, and professional bodies.
Clinical decisions, including prescribing decisions, will remain for the treating clinician, informed by professional judgement, the available evidence, and relevant guidance. Each clinician is responsible for keeping that knowledge up to date. Integrated care boards, primary care providers, and National Health Service trusts are also expected to keep abreast of emerging evidence and guidance and consider it through their clinical governance arrangements.
There is currently no routine national data collection on the number of children and young people affected by paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS).
The Steering Group’s Research Group is progressing work to improve understanding of the number of children and young people affected. Applications have been made to the independent British Paediatric Surveillance Unit and Child and Adolescent Psychiatry Surveillance System.
Information on research funded through the National Institute for Health and Care Research (NIHR) relating to PANS and PANDAS is available through the NIHR Funding and Awards website. The NIHR welcomes applications for research into all aspects of human health, including PANS and PANDAS. The NIHR Funding and Awards website is available at the following link:
Minister of State (Department of Health and Social Care)
We recognise that it is important that people are discharged promptly from the hospital with the right support, both for their outcomes and to free up beds for other patients.
We are continuing to work with National Health Service trusts and local authorities to embed best practice in discharge processes. Areas experiencing the most significant challenges with discharge delays and urgent and emergency care performance are receiving targeted support to drive those improvements. The recently published NHS England Model Discharge Pathway sets out good practice to support timely, safe discharge from hospital, and reduce unwarranted variation in discharge processes across wards and organisations.
We are also working to strengthen intermediate care capacity, and this includes through the Better Care Fund investing £9 billion in services that help people regain independence and prevent avoidable admissions, including intermediate care, rehabilitation, and reablement services.
Minister of State (Department of Health and Social Care)
I refer the Hon Member to the answer provided on 8 July in response to Question 10871.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information requested is not available as it has not been centrally validated.
Parliamentary Under-Secretary (Department of Health and Social Care)
The information requested is not available as it has not been centrally validated.
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the Department’s strategy on Living with and Beyond Cancer in Chapter 4 of the National Cancer Plan available at the link below, which examines these and other issues in detail:
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the Department’s strategy on Living with and Beyond Cancer in Chapter 4 of the National Cancer Plan available at the link below, which examines these and other issues in detail:
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the Department’s strategy on Living with and Beyond Cancer in Chapter 4 of the National Cancer Plan available at the link below, which examines these and other issues in detail:
Parliamentary Under-Secretary (Department of Health and Social Care)
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
Parliamentary Under-Secretary (Department of Health and Social Care)
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
Parliamentary Under-Secretary (Department of Health and Social Care)
Some of the data requested by the Hon. Member is not centrally held, but on the wider issues raised, I refer him to the answer provided on 3 March in response to Question 115098. Available data on this issue is also published by the National Institute for Health and Care Research at the following link:
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to Annex A of the National Institute for Health and Care Excellence Topic Selection Manual, published on 25 August, which is available at the following link:
https://www.nice.org.uk/process/pmg46/chapter/annex-a-national-healthtech-access-programme
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon. Member to Annex A of the National Institute for Health and Care Excellence Topic Selection Manual, published on 25 August, which is available at the following link:
https://www.nice.org.uk/process/pmg46/chapter/annex-a-national-healthtech-access-programme
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the National Cancer Plan for England, published in February, which sets out the steps we are taking in a range of areas to improve cancer diagnosis, treatment, and outcomes, including for research and clinical trials. The National Cancer Plan for England is available at the following link:
I also refer the Hon Member to the answer provided on 24 February 2026 to the Hon Member for Sheffield South East to Question 113042.
Parliamentary Under-Secretary (Department of Health and Social Care)
I refer the Hon Member to the National Cancer Plan for England, published in February, which sets out the steps we are taking in a range of areas to improve cancer diagnosis, treatment, and outcomes, including for research and clinical trials. The National Cancer Plan for England is available at the following link:
I also refer the Hon Member to the answer provided on 24 February 2026 to the Hon Member for Sheffield South East to Question 113042.
Parliamentary Under-Secretary (Department of Health and Social Care)
Charlie Dewhirst
(Conservative - Bridlington and The Wolds)
The requested information is not held centrally by the Department and could only be collated and verified at disproportionate cost.
Parliamentary Under-Secretary (Department of Health and Social Care)
We can confirm that Tom Kibasi does not work for the Department.
Parliamentary Under-Secretary (Department of Health and Social Care)
James McMurdock
(Independent - South Basildon and East Thurrock)
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
Parliamentary Under-Secretary (Department of Health and Social Care)
James McMurdock
(Independent - South Basildon and East Thurrock)
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
Parliamentary Under-Secretary (Department of Health and Social Care)
James McMurdock
(Independent - South Basildon and East Thurrock)
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
Parliamentary Under-Secretary (Department of Health and Social Care)
James McMurdock
(Independent - South Basildon and East Thurrock)
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
Parliamentary Under-Secretary (Department of Health and Social Care)
James McMurdock
(Independent - South Basildon and East Thurrock)
I refer the Hon. Member to the answer provided on 15 June in response to Question 6594.
Departmental officials meet on a regular basis with patient organisations, integrated care boards and other stakeholders to discuss the improvement of National Health Service care for a range of conditions. External meetings of that nature held by ministers and senior officials are reported on a quarterly basis in the Department’s transparency publications.
Parliamentary Under-Secretary (Department of Health and Social Care)
Andrew Snowden
(Conservative - Fylde)
I refer the Hon. Member to the answer given on 16 July 2026 to Question 17477.
Parliamentary Under-Secretary (Department of Health and Social Care)
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
Parliamentary Under-Secretary (Department of Health and Social Care)
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
Parliamentary Under-Secretary (Department of Health and Social Care)